The inflamed plaque: Cytokine production and cellular cholesterol balance in the vessel wall

American Journal of Cardiology

Volumn 88, Issue 2 SUPPL. 1, 2001, Pages 12-15

  Fazio, Sergio ^a   Linton, MacRae F ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A; ACYLTRANSFERASE; ADENOSINE TRIPHOSPHATE; CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE; GAMMA INTERFERON; SCAVENGER RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTERY LESION; ARTERY WALL; ATHEROSCLEROTIC PLAQUE; CYTOKINE PRODUCTION; CYTOPLASM; FOAM CELL; GENE CASSETTE; HUMAN; HYPERLIPIDEMIA; INFLAMMATION; LIPID STORAGE; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0035913109     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(01)01717-9     Document Type: Article

References (39)

1. Retroviral gene therapy in apoE-deficient mice: apoE expression in the artery wall reduces early foam cell lesion formation
2. Increased atherosclerosis in C57BL/6 mice reconstituted with apolipoprotein E null macrophages
3. Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo
4. A direct role for macrophage LDL receptor in atherosclerotic lesion formation
5. Reduced atherosclerotic lesions in mice deficient for total or macrophage-specific expression of scavenger receptor-A
6. Increased atherosclerosis in LDL receptor-null mice lacking ACAT1 in macrophages
7. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
8. Systemic nature of endothelial dysfunction in atherosclerosis
9. The pathogenesis of atherosclerosis: A perspective for the 1990s
10. Biology of disease. The pathogenesis of atherosclerosis: Atherogenesis and inflammation
11. Immune mechanisms in atherosclerosis
12. Biology of disease. Involvement of the immune system in human atherogenesis. Current knowledge and unanswered questions
13. Inflammatory and immunological nature of atherosclerosis
14. Signal transduction in atherosclerosis: Second messengers and regulation of cellular cholesterol trafficking
15. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40-CD40 ligand signaling in atherosclerosis
16. A central role of CD40 ligand in the regulation of CD4+ T-cell responses
17. The role of interleukin 12 in the development of atherosclerosis in apo E-deficient mice
18. T-lymphocytes and monocytes in atherogenesis
19. Prospective studies of C-reactive protein as a risk factor for cardiovascular disease
20. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels
21. Long-term effects of pravastatin on plasma concentration of C-reactive protein
22. Very low-density lipoprotein activates nuclear factor-kappaB in endothelial cells
23. The nuclear transcription factor NF-kappaB mediates interleukin-1beta-induced expression of cyclooxygenase-2 in human myometrial cells
24. Superoxide attenuates macrophage apoptosis by NF-kappa B and AP-1 activation that promotes cyclooxygenase-2 expression
25. Inflammation, lipids, and free radicals: Lessons learned from the atherogenic process
26. Lymphocyte populations in atherosclerotic lesions of apoE -/- and LDL receptor -/- mice. Decreasing density with disease progression
27. Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes, in vivo
28. Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice
29. Atherosclerosis: An inflammatory disease
30. Interferon-γ elicits arteriosclerosis in the absence of leukocytes
31. Regulation of cholesterol distribution in macrophage-derived foam cells by interferon-γ
32. Interferon-γ induces downregulation of Tangier disease gene (ATP-binding-cassette transporter-1) in macrophage-derived foam cells
33. A PPARg-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis
34. Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking ACAT1
35. The ACAT inhibitor avasimibe reduces macrophages and matrix metalloproteinase expression in atherosclerotic lesion of hypercholesterolemic rabbits
36. Accelerated atherosclerosis in mice lacking tumor necrosis factor receptor p55
37. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
38. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
39. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1